Table 1.
Main characteristics of included studies evaluating the relationship between malaria infection and epilepsy
| Author | Country | Type of study | Type of population | Diagnostic methods | Number of cases | Positive outcome | Number of controls | Positive outcome | Quality score |
|---|---|---|---|---|---|---|---|---|---|
| Versteeg et al. (2003)a | Kenya | Retrospective cohort | Children | Slide-positive malaria | 35 | 11 | 46 | 3 | Moderate |
| Carter et al. (2004)a | Kenya | Retrospective cohort | Children | Slide-positive malaria | 152 | 14 | 179 | 4 | High |
| Ngoungou et al. (2006a)a | Mali | Prospective cohort | Children | Slide-positive malaria | 101 | 5 | 222 | 0 | High |
| Ngoungou et al. (2006b)b | Gabon | Case–control | Adult and children | Malaria IgG + ve (schizont) | 296 | 45 | 296 | 12 | Moderate |
| Idro et al. (2008)b | Kenya | Cross-sectional | Children | Slide-positive malaria | 900 | 479 | 4021 | 482 | High |
| Opoka et al. (2009)a | Uganda | Prospective cohort | Children | Slide-positive malaria | 68 | 8 | 92 | 4 | Moderate |
| Birbeck et al. (2010)a | Malawi | Prospective cohort | Children | Slide-positive malaria | 132 | 12 | 264 | 0 | High |
| Postels et al. (2012)a | Malawi | Prospective cohort | Children | Slide-positive malaria | 167 | 18 | 272 | 0 | High |
| Ngugi et al. (2013)b | Sub-Saharan Africa | Cross-sectional | Adult | Malaria IgG + ve (schizont) | 563 | 473 | 703 | 596 | Moderate |
| Ngugi et al. (2013)b | Sub-Saharan Africa | Cross-sectional | Children | Malaria IgG + ve (schizont) | 423 | 333 | 610 | 491 | Moderate |
| Kamuyu et al. (2014)b | South Africa | Case–control | Adult and children | Malaria IgG + ve (schizont) | 175 | 40 | 211 | 70 | High |
| Kamuyu et al. (2014)b | Tanzania | Case–control | Adult and children | Malaria IgG + ve (schizont) | 278 | 270 | 345 | 323 | High |
| Kamuyu et al. (2014)b | Uganda | Case–control | Adult and children | Malaria IgG + ve (schizont) | 84 | 84 | 199 | 198 | High |
| Kamuyu et al. (2014)b | Ghana | Case–control | Adult and children | Malaria IgG + ve (schizont) | 173 | 173 | 292 | 291 | Moderate |
| Kamuyu et al. (2014)b | Kenya | Case–control | Adult and children | Malaria IgG + ve (schizont) | 276 | 209 | 266 | 203 | Moderate |
| Wagner et al. (2014)b | South Africa | Cross-sectional | Adult and children | Malaria IgG + ve (schizont) | 292 | 71 | 260 | 78 | Moderate |
| Ae-Ngibise et al. (2015)b | Ghana | Cross-sectional | Adult | Malaria IgG + ve (schizont) | 188 | 187 | 175 | 175 | High |
| Ae-Ngibise et al. (2015)b | Ghana | Cross-sectional | Children | Malaria IgG + ve (schizont) | 93 | 93 | 117 | 116 | High |
| Bistervels et al. (2016)b | Kenya | Cross-sectional | Adult and children | Slide-positive malaria | 150 | 96 | 2841 | 1679 | High |
| Kakooza-Mwesige et al. (2017)b | Uganda | Cross-sectional | Adult | Slide-positive malaria | 65 | 5 | 100 | 4 | Moderate |
| Kakooza-Mwesige et al. (2017)b | Uganda | Cross-sectional | Children | Slide-positive malaria | 157 | 7 | 172 | 10 | Moderate |
| Thierry et al. (2020)b | Benin | Case–control | Children | Slide-positive malaria | 41 | 29 | 82 | 12 | Moderate |
| Gumisiriza et al. (2021)b | Uganda | Case–control | Children | Medical history | 154 | 38 | 153 | 43 | Moderate |
| Dolo et al. (2022)b | Mali | Cross-sectional | Adult and children | Medical history | 1322 | 470 | 1991 | 88 | High |
Malaria-based studies.
Epilepsy-based studies.